Jim Cramer Reveals How CVS Health Corporation (CVS) is "Saving a Lot of Money"

By Ramish Cheema | January 09, 2026, 12:04 PM

We recently published 9 Stocks Jim Cramer Talked About.  CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer talked about.

CVS Health Corporation (NYSE:CVS) is one of the largest pharmaceutical chains in America. Its shares are up by 73% over the past year. JPMorgan named the firm as a Top Pick in December, as it pointed out that CVS Health Corporation (NYSE:CVS)’s investor day had left it impressed about the firm’s earnings growth throughout 2028. The bank also raised the share price target to $101 from $93 and kept an Overweight rating on the shares. Bernstein also shared an optimistic take about CVS Health Corporation (NYSE:CVS) in December as it bumped the price target to $87 from $86 and maintained a Market Perform rating. The optimism also stemmed from the pharma firm’s investor day, with Bernstein left impressed by CVS Health Corporation (NYSE:CVS)’s management team and market leadership. As for Cramer, he shared additional insights about the firm’s operations:

Jim Cramer Reveals How CVS Health Corporation (CVS) is "Saving a Lot of Money"
Pixabay/Public Domain

“Take David Joiner, who’s really a revolutionary at CVS, and they’ve really implemented Salesforce. And they’re saving a lot of money. Because it’s the agentics, because anybody has a business where you just call and you’re left on hold, that’s over. That’s important.”

While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

Mentioned In This Article

Latest News